Oregon Health and Science University
1,074
148
200
603
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.9%
128 terminated/withdrawn out of 1074 trials
82.5%
-4.1% vs industry average
11%
114 trials in Phase 3/4
48%
291 of 603 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1074)
Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other Disorders
Role: collaborator
Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
Role: collaborator
Adaptive Coping Skills Training to Improve Psychological Distress Among Cardiorespiratory Failure Survivors
Role: collaborator
Sleep and Circadian Mechanisms of Non-dipping Blood Pressure
Role: lead
Patient Empowerment and Agency Through Intrapartum Counseling and Education
Role: lead
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Role: collaborator
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
Role: collaborator
Peer Support Program for Improving Quality of Life Among Head and Neck Patients, Connecting Through Cancer Trial
Role: collaborator
Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer
Role: collaborator
Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia
Role: collaborator
Identifying and Caring for Individuals With Inherited Cancer Syndrome
Role: collaborator
Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
Role: collaborator
A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial
Role: collaborator
Disparities in Emergency Contraceptive Metabolism Dictate Efficacy
Role: lead
Extended Post-operative Oral TXA in Primary THA
Role: lead
Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors
Role: collaborator
Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma
Role: collaborator
Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma
Role: collaborator
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
Role: collaborator
Implementing Powered Mobility in Early Childhood Settings for Children With Cerebral Palsy
Role: lead